SALUS, Ljubljana, d. d. (LJSE:SALR)

Market Cap	526.03M +144.7%
Revenue (ttm)	696.19M +7.3%
Net Income	16.68M +29.8%
EPS	2.03 +29.8%
Shares Out	8.22M
PE Ratio	31.53
Forward PE	n/a
Dividend	1.20 (1.88%)
Ex-Dividend Date	Apr 28, 2026

Volume	252
Average Volume	2,233
Open	64.00
Previous Close	n/a
Day's Range	64.00 - 64.00
52-Week Range	28.97 - 72.50
Beta	0.59
RSI	48.85
Earnings Date	May 7, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1969
• Employees: 618
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: SALR

Financial Performance

In 2025, SALUS, Ljubljana, d. d.'s revenue was 696.19 million, an increase of 7.30% compared to the previous year's 648.83 million. Earnings were 16.68 million, an increase of 29.78%.